tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IDYA Stock Latest News

Ideaya Biosciences announces FDA clearance of IDE034 IND application
The FlyIdeaya Biosciences announces FDA clearance of IDE034 IND application
3d ago
IDYA
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
PremiumThe Fly
Ideaya Biosciences announces inducement grants under Nasdaq listing rule
6d ago
IDYA
Ideaya Biosciences initiated with a Buy at Truist
PremiumThe Fly
Ideaya Biosciences initiated with a Buy at Truist
10d ago
IDYA
Ideaya Biosciences price target raised to $46 from $44 at Mizuho
PremiumThe Fly
Ideaya Biosciences price target raised to $46 from $44 at Mizuho
23d ago
IDYA
IDEAYA Biosciences: Strong Buy Rating Backed by Promising Pipeline and Robust Financial Position
PremiumRatings
IDEAYA Biosciences: Strong Buy Rating Backed by Promising Pipeline and Robust Financial Position
29d ago
IDYA
IDEAYA Biosciences Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsIDEAYA Biosciences Reports Strong Q3 2025 Results
30d ago
IDYA
IDEAYA Biosciences: Promising Clinical Developments and Strategic Potential Drive Buy Rating
Premium
Ratings
IDEAYA Biosciences: Promising Clinical Developments and Strategic Potential Drive Buy Rating
1M ago
IDYA
IDEAYA Biosciences: Strong Clinical Data and Financial Position Justify Buy Rating
Premium
Ratings
IDEAYA Biosciences: Strong Clinical Data and Financial Position Justify Buy Rating
1M ago
IDYA
Ideaya Biosciences price target raised to $79 from $74 at JPMorgan
PremiumThe Fly
Ideaya Biosciences price target raised to $79 from $74 at JPMorgan
1M ago
IDYA
Ideaya Biosciences price target raised to $30 from $27 at Goldman Sachs
PremiumThe Fly
Ideaya Biosciences price target raised to $30 from $27 at Goldman Sachs
1M ago
IDYA
Ideaya Biosciences price target raised to $41 from $38 at RBC Capital
PremiumThe Fly
Ideaya Biosciences price target raised to $41 from $38 at RBC Capital
1M ago
IDYA
Promising Potential of IDEAYA Biosciences’ Darovasertib: Strong Efficacy and Safety in Uveal Melanoma Trials
PremiumRatings
Promising Potential of IDEAYA Biosciences’ Darovasertib: Strong Efficacy and Safety in Uveal Melanoma Trials
1M ago
IDYA
IDEAYA Biosciences Presents Promising Phase 2 Data
PremiumCompany AnnouncementsIDEAYA Biosciences Presents Promising Phase 2 Data
1M ago
8K
IDYA
IDEAYA Biosciences: Promising Phase 1/2 Trial Results and Strong Upside Potential Justify Buy Rating
Premium
Ratings
IDEAYA Biosciences: Promising Phase 1/2 Trial Results and Strong Upside Potential Justify Buy Rating
2M ago
IDYA
Ideaya Biosciences presents clinical data from OptimUM-09 trial
Premium
The Fly
Ideaya Biosciences presents clinical data from OptimUM-09 trial
2M ago
IDYA
Ideaya Biosciences reports overall survival data from darovasertib trial
PremiumThe Fly
Ideaya Biosciences reports overall survival data from darovasertib trial
2M ago
PFE
IDYA
Promising Potential of IDEAYA Biosciences: Strong Efficacy and Financial Stability Support Buy Rating
PremiumRatings
Promising Potential of IDEAYA Biosciences: Strong Efficacy and Financial Stability Support Buy Rating
2M ago
IDYA
IDEAYA Biosciences: Promising Outlook for Darovasertib in Uveal Melanoma Drives Buy Rating
PremiumRatings
IDEAYA Biosciences: Promising Outlook for Darovasertib in Uveal Melanoma Drives Buy Rating
2M ago
IDYA
Ideaya Biosciences Advances IDE849 Study for DLL3-Expressing Tumors
PremiumCompany Announcements
Ideaya Biosciences Advances IDE849 Study for DLL3-Expressing Tumors
2M ago
IDYA
Promising Developments in IDEAYA Biosciences’ Pipeline Drive Buy Rating with $74 Price Target by 2026
PremiumRatingsPromising Developments in IDEAYA Biosciences’ Pipeline Drive Buy Rating with $74 Price Target by 2026
2M ago
IDYA
JPMorgan places ‘Positive Catalyst Watch’ on Ideaya into updates
Premium
The Fly
JPMorgan places ‘Positive Catalyst Watch’ on Ideaya into updates
2M ago
IDYA
Ideaya Biosciences initiated with a Buy at Guggenheim
Premium
The Fly
Ideaya Biosciences initiated with a Buy at Guggenheim
3M ago
IDYA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >